Ahmed Abdulla
Founder/CEO
The pioneer of sustainable and value-based healthcare delivery, innovative evidence generation and p...
Digipharm has built the world’s first blockchain-based platform for value-based contracting of healthcare technologies and healthcare services. In healthcare there is a clear shift to payments using a ‘value-based’ approach, where the price paid is determined by performance, for example, patient benefits and real-life patient outcomes. According to Deloitte, 75% of payments in healthcare are to be value based by 2020. This approach to healthcare payments is not just relevant for pharmaceuticals or drug treatments; pricing agreements and contracting for medical devices and healthcare services have also been shifting to an approach based on outcomes and key performance indicators. However one of the biggest limiting factors is the infrastructural limitations that are experienced when implementing these types of agreements. Since patient data and patient outcomes is used to determine the cost of care, Digipharm uses blockchain technology to create a medical information infrastructure that enables trust and a synchronized overview in these outcomes for all contracting parties. Digipharm’s smart contracts coded in the blockchain also remove the administrative burden of tracking and executing these agreements.
Jun 14th, 2019 3:00 am (UTC)
Jun 18th, 2019 3:00 am (UTC)
United Kingdom
DPH
Ethereum
Utility
100 000 000DPH
35 000 000 DPH (35.0000% of total token supply)
1 DPH = 0.1 USD
Standard
DIGIPHARM
United Kingdom
London , UK EC1V 2NX, GB
Required
United States, China
Bitcoin has survived 472 death calls since 2011, gaining 701,300x. Now trading near $75,382 in tight consolidation, here’s what the technicals say about BTC’s next move.
Bitcoin spot price hovers near $75,866 as a $1.289B IBIT dark pool sale triggers intraday reversal. Futures markets stay active while key resistance sits at $79,600–$82,000.
SOL is down 65% from 2025 highs and trading near $86 amid broad risk-off conditions. On-chain metrics remain strong, but ETF outflows and macro headwinds keep bear market fears elevated. Full price analysis inside.